Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

Q4 2024 Earnings Call Transcript February 13, 2025 Blueprint Medicines Corporation misses on earnings expectations. Reported ...

Telix Pharmaceuticals Ltd.’s prostate cancer PET imaging agent Illuccix has been approved by the Danish Medicines Agency.

AI has already improved dental care, but a $500B Trump AI investment plan promises even better advancements. Here are five ...

A CARLISLE mother who is fighting a rare form of cancer has thanked the community who have supported her on a journey of holistic medicine.

The purpose of this study was to evaluate the usefulness of positron emission tomography with 18F-2-deoxyglucose (FDG-PET) for the detection of malignant bone metastases, and to compare FDG-PET ...

A teenage rugby player had his leg amputated after what he thought was a lump from a rugby tackle turned out to be an aggressive bone cancer. Oliver Liddle, who is a full-time gym instructor, says he ...

Most of the patients with positive bone scan findings were treated for osteomyelitis without pathologic confirmation, though 12/48 total patients did have pathologic confirmation, either through ...

From amphibians to reptiles to all the creatures living under the sea, Kelly Geck takes care of them all at the Cook Museum of Natural Science, and the Ohio native said she finds the ecosystem in ...

With threats of avian flu and lead poisoning, biologists are working overtime to care for a species that nearly went extinct.

Learn More Telix Pharmaceuticals Ltd (ASX: TLX) shares are ending the week on a positive note ... replacing conventional imaging methods (bone scan, CT6 scan) as the standard of care after ...